| Literature DB >> 32071359 |
Hatem Ali1,2, Abdel Rahman Al-Khalifa1, Abdelhakim Aouf3, Habiba Boukhebti4, Amr Farouk5.
Abstract
Nanoencapsulation is an attractive novel technique used for incorporating essential oils in food preparations and pharmaceutical formulae. This study investigated the effect of nanoencapsulation on the composition of volatile compounds, as well as the antioxidant and anticancer activities of hydrodistilled (HD) Origanum glandulosum Desf. Oil, which was encapsulated into nanocapsules via High Speed Homogenization (HSH) and into nanoemulsions through High Pressure Homogenization (HPH). Thirty-two volatile components were identified using Gas Chromatography-Mass Spectrometry analysis (GC-MS) in HD essential oil representing 99.04% of the total oil content. GC-MS analysis showed that the use of HPH to prepare nanoemulsions negatively affected the active compounds present in HD oil, particularly carvacrol and thymol, whereas the use of HSH led to significant quantitative differences in the composition of volatiles between HD oil and nanocapsules but generated the same profile. Consistent with the differences in total phenolics, total flavonoids, and volatiles identified in HD and nanoparticles, HD essential oil exhibited a higher antioxidant activity (IC50 4.22 mg/mL) than nanocapsules (IC50 57.51 mg/mL) and nanoemulsion (IC50 78.50 mg/mL), while nanocapsules showed the strongest cytotoxic effect on liver cancer cell line Hep-G2 (54.93 μg/mL) in comparison to HD oil (73.13 μg/mL) and nanoemulsions (131.6 μg/mL).Entities:
Mesh:
Substances:
Year: 2020 PMID: 32071359 PMCID: PMC7028938 DOI: 10.1038/s41598-020-59686-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Volatile constituents identified from the hydrodistilled (HD), nanocapsules and nanoemulsion of O. glandulosum essential oil using GC-MS.
| S/N | Compound | KIa | % Areab
| Identification methodc,d | ||
|---|---|---|---|---|---|---|
| HD | Nanoemulsion | Nanocapsules | ||||
| 1 | α-Thujene | 928 | n.d. | MS, KI, & ST | ||
| 2 | α-Pinene | 932 | 0.79 ± 0.06 | MS, KI, & ST | ||
| 3 | Camphene | 971 | 0.12 ± 0.03 | MS & KI | ||
| 4 | β–Pinene | 978 | 0.20 ± 0.12 | n.d. | n.d. | MS & KI |
| 5 | β–Myrcene | 991 | n.d. | MS, KI, & ST | ||
| 6 | α-Phellandrene | 998 | 0.21 ± 0.04 | n.d. | 0.33 ± 0.08 | MS & KI |
| 7 | Δ–3-Carene | 1001 | 0.10 ± 0.06 | n.d. | MS & KI | |
| 8 | α-Terpinene | 1004 | n.d. | n.d. | MS, KI, & ST | |
| 9 | p-Cymene | 1008 | MS, KI, & ST | |||
| 10 | Limonene | 1029 | n.d. | 0.72 ± 0.07 | 0.56 ± 0.04 | MS & KI |
| 11 | γ-Terpinene | 1088 | MS, KI,& ST | |||
| 12 | Linalool | 1089 | 0.37 ± 0.05 | 0.73 ± 0.07 | MS & KI | |
| 13 | Camphor | 1141 | n.d. | n.d. | MS & KI | |
| 14 | Borneol | 1148 | 0.10 ± 0.07 | n.d. | MS & KI | |
| 15 | Terpinen-4-ol | 1155 | 0.30 ± 0.06 | 0.65 ± 0.08 | MS & KI | |
| 16 | α-Terpineol | 1165 | 0.49 ± 0.10 | 0.62 ± 0.22 | MS & KI | |
| 17 | Thymol methyl ether | 1231 | 0.19 ± 0.07 | n.d. | n.d. | MS & KI |
| 18 | Carvacrol methyl ether | 1240 | 0.24 ± 0.08 | n.d. | n.d. | MS & KI |
| 19 | Thymol | 1267 | MS, KI, & ST | |||
| 20 | Carvacrol | 1276 | MS, KI, & ST | |||
| 21 | β–Cubebene | 1385 | 0.33 ± 0.05 | n.d. | n.d. | MS & KI |
| 22 | β–Caryophyllene | 1414 | 0.82 ± 0.10 | MS, KI,& ST | ||
| 23 | α-Humulene | 1451 | 0.72 ± 0.17 | n.d. | n.d. | MS & KI |
| 24 | Germacrene D | 1472 | n.d. | n.d. | MS, KI, & ST | |
| 25 | Bicyclogermacrene | 1489 | 0.14 ± 0.03 | n.d. | n.d. | MS & KI |
| 26 | α-Muurolene | 1491 | 0.06 ± 0.04 | n.d. | n.d. | MS & KI |
| 27 | β–Bisabolene | 1502 | 0.52 ± 0.07 | n.d. | 0.72 ± 0.07 | MS & KI |
| 28 | γ-Cadinene | 1509 | n.d. | n.d. | MS, KI, & ST | |
| 29 | γ-Bisabolene | 1511 | 0.29 ± 0.07 | n.d. | 0.36 ± 0.04 | MS & KI |
| 30 | Spathulenol | 1561 | 0.16 ± 0.08 | n.d. | n.d. | MS & KI |
| 31 | Caryophyllene oxide | 1576 | 0.23 ± 0.08 | n.d. | n.d. | MS & KI |
| 32 | α–epi- Muurolol | 1638 | 0.71 ± 0.08 | n.d. | n.d. | MS & KI |
| 33 | Torreyol | 1641 | 0.14 ± 0.03 | n.d. | n.d. | MS & KI |
| 34 | α-Cadinol | 1649 | n.d. | n.d. | MS, KI, & ST | |
| Total | — | — | ||||
aConfirmed by comparison with Kovat’s index on a DB5 column (Adams 2007).
bValues represent averages ± standard deviations for triplicate experiments.
cConfirmed by comparison with the mass spectrum of the authentic compound.
dIdentification by comparison with data obtained from the NIST mass spectra library.
n.d: not detected.
Figure 1Volatile chromatograms for (A) O. glandulosum Desf. HD oil, (B) nanoemulsion of O. glandulosum Desf. oil, and (C) nanocapsules of O. glandulosum Desf. oil.
Antioxidant activity of HD, nanocapsules and nanoemulsion of O. glandulosum Desf. essential oil in comparison to the synthetic antioxidant TBHQ.
| Material | IC50/mg/ml(DPPH)a | Total flavonoid content a mg CE/g | Total phenolic content a mg RE/g |
|---|---|---|---|
| for 1 mg/ml | for 1 mg/ml | ||
| 4.22 ± 0.13a | 0.458 ± 0.02a | 0.994 ± 0.01a | |
| Nanocapsules of | 57.51 ± 0.26b | 0.312 ± 0.01b | 0.756 ± 0.03b |
| Nanoemulsion of | 78.50 ± 1.13c | 0.183 ± 0.01c | 0.430 ± 0.09c |
| TBHQ | 1.39 ± 0.12d | — | — |
aValues represent averages ± standard deviations for triplicate experiments. Means with the same letter within the same row are not significantly different (P > 0.05).
Figure 2Transmission electron microscope (TEM) images: (A) nanoemulsion of O. glandulosum Desf. oil, and (B) nanocapsules of O. glandulosum Desf. oil.
Figure 3Evaluation of cell viability percentage of liver cancer cell line (Hep G2) post treatment (A) O. glandulosum Desf. HD oil, (B) nanoemulsion of O. glandulosum Desf. oil, and (C) nanocapsules of O. glandulosum Desf. oil compared with reference drug (D) 5-Fu using MTT assay.
Figure 4Evaluation of cell viability percentage of Healthy human hepatic cells (THLE2) post treatment (A) O. glandulosum Desf. HD oil, (B) nanoemulsion of O. glandulosum Desf. oil, and (C) nanocapsules of O. glandulosum Desf. oil compared with reference drug (D) 5-Fu using MTT assay.